Top Markets
Coin of the day
Jinling Pharmaceutical Company Limited Jinling Pharmaceutical Company Limited

Jinling Pharmaceutical Company Limited

000919
Rang in Aktien #12260
Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in... Jinling Pharmaceutical Company Limited is a Chinese enterprise specializing in the manufacture and distribution of a diverse range of pharmaceutical products. Its key offerings include the Mailuoning injection, prescribed for the management of numerous vascular and thrombotic conditions such as thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and its sequelae, multiple forms of arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, and thrombophlebitis. The company also provides ferrous succinate tablets for the prevention and treatment of iron deficiency anemia, alongside lentinan injection used in the therapy of malignant tumors. Furthermore, Jinling Pharmaceutical offers medical health care services. The firm's operations are primarily based in Nanjing, China.
Aktienkurs
$0.96802475
Marktkapitalisierung
$602.04M
Veränderung (1 Tag)
-2.48%
Veränderung (1 Jahr)
-2.91%
Land
CN
Handel Jinling Pharmaceutical Company Limited (000919)

Kategorie

Aktien-Split-Historie für Jinling Pharmaceutical Company Limited (000919)
Die Aktie Jinling Pharmaceutical Company Limited (Symbol: 000919) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 31, 2026 statt.
Eine 000919-Aktie, die vor dem Aug 31, 2026 gekauft wurde, entspricht heute 0 000919-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber